Target intelligence / Profile preview

Glyceraldehyde-3-phosphate dehydrogenase pseudogene 24 (GAPDHP24)

Target
GAPDHP24
Molecular classification
Pseudogene
01

Overview

GAPDHP24 stands for "glyceraldehyde-3-phosphate dehydrogenase pseudogene 24," a non-functional, non-protein-coding pseudogene in the human genome with high sequence homology to the functional GAPDH gene. Unlike GAPDH, which encodes an essential glycolytic enzyme and has multiple cellular roles, pseudogenes like GAPDHP24 do not produce active proteins, do not participate in metabolism, and are not studied as therapeutic drug targets. While some pseudogenes can have minor regulatory effects at the RNA level, there is no evidence that GAPDHP24 has biological function or relevance in health or disease[3]. Key clarifications: - If you intend information on the true metabolic enzyme, the correct entry would be "glyceraldehyde-3-phosphate dehydrogenase" (GAPDH), a major glycolytic enzyme with well-defined biological functions and some disease relevance[1][2][3][4]. - GAPDHP24 is not the same as GAPDH, is not a drug target, and has no known function.

Other names
Glyceraldehyde-3-phosphate dehydrogenase pseudogene 24GAPDH pseudogene 24GAPDHP24

Beyond the preview

Go deeper on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 24 (GAPDHP24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyceraldehyde-3-phosphate dehydrogenase pseudogene 24 (GAPDHP24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call